Calithera Biosciences, Inc. (CALA)
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Sector: Biotechnology
Industry: Biotechnology
Calithera Biosciences, Inc.
- 0.1%
- 6.8K
- 7.95
Float 4.83M · FMP free float
The cost to borrow CALA shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- No fails on record for 16–31 Oct 2026.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 6.8K sh |
| Oct 15, 2026 | 6.9K sh |
| Sep 30, 2026 | 7.1K sh |
| Sep 15, 2026 | 7.2K sh |
| Aug 31, 2026 | 7.2K sh |
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
FINRA publishes no off-exchange short volume for this symbol.
FINRA's weekly alternative trading system (dark pool) volume for CALA: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 6,803 CALA shares were sold short (0.14% of a 4.83M-share float, 7.95 days to cover).